Medscan Group closed the deal on the purchase of the KDL laboratory network

Medscan Group bought the KDL laboratory network from UFG Private Equity. According to the Unified State Register of Legal Entities, the deal was closed on December 27. The representative of “Medscan” confirmed this information, specifying that the company “Diagnostics” (the main legal entity of KDL) became the property of one of the subsidiaries of the group.

The parties did not disclose the amount of the transaction. Mikhail Burmistrov, CEO of Infoline Analytics, estimates the cost of KDL at 15 billion rubles. A source close to one of the parties to the transaction assures that it is higher – 19-20 billion rubles.

Launched in 2003, the KDL network includes 13 regional laboratories and over 350 medical offices in more than 40 Russian cities. The company’s patient traffic in 2022, according to its CEO Yuri Leonov, will amount to 2.5 million patients. According to him, the network will be able to additionally attract more than 50,000 patients for Medscan clinics. The united company plans to participate in public-private programs and develop the CMI area.

In 2021, the total revenue of the operating structures of the network – KDL-test LLC and KDL Domodedovo-test LLC – amounted to 13.6 billion rubles, net profit – 2.2 billion rubles. The total debt at the end of last year was at the level of 1.98 billion rubles.

For UFG, the acquisition of KDL was the first investment in healthcare in Russia. In 2012, her fund, together with CapMan Russia and the European Bank for Reconstruction and Development (EBRD), bought a 75% stake in the network from its founders, Alexander Devyatkov and Vladimir Polyakov. CapMan received 24% of the company, EBRD – 10.7%, UFG Private Equity – 40.3%. The latter soon consolidated 100% of KDL.

The representative of the company explains the withdrawal from the project by the fact that the term of the UFG Private Equity funds is 10-12 years, so she began looking for a buyer for this asset back in 2021. He did not specify whether the company was able to make money on the deal.

The Medscan network of diversified medical companies was established in 2014 by businessman Evgeny Tugolukov. It includes 58 medical centers in 20 Russian regions. Among them are diagnostic centers, hospitals with a surgical hospital, multidisciplinary and specialized clinics, including oncological ones. The flagship asset of the group is a branch of the Israeli hospital Hadassah. Medscan also has its own laboratory centers based on multidisciplinary clinics, in particular in Moscow, Kursk, and Perm.

At the beginning of this year, Rusatom Healthcare acquired 25.001% of the Medscan group, while Tugolukov remained the majority shareholder with 74.99% of the capital.

In the ranking of the top 20 largest private multidisciplinary clinics in 2021, compiled by the industry publication Vademecum, Medscan ranks 13th with a revenue of 4.3 billion rubles. VHI accounts for 11.3% of its revenue, CHI – 11.3%, the rest – direct payments.

In 2022, Medscan bought the Russian business of the Israeli network of On Clinic International medical centers – Medical On Group. At the end of 2021, its revenue amounted to 2.97 billion rubles, net profit – 350 million rubles. In 2022, this indicator is expected to reach 400 million rubles.